Private Trust Co. NA Purchases 141 Shares of Danaher Co. (NYSE:DHR)

Private Trust Co. NA raised its holdings in shares of Danaher Co. (NYSE:DHR) by 2.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,459 shares of the conglomerate’s stock after purchasing an additional 141 shares during the quarter. Private Trust Co. NA’s holdings in Danaher were worth $1,518,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of DHR. Fort Pitt Capital Group LLC increased its position in shares of Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after acquiring an additional 7,421 shares in the last quarter. Good Life Advisors LLC bought a new stake in Danaher during the 3rd quarter worth approximately $217,000. Oak Thistle LLC purchased a new stake in shares of Danaher in the second quarter worth approximately $363,000. Harvest Portfolios Group Inc. boosted its position in shares of Danaher by 1.2% during the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after buying an additional 2,465 shares during the last quarter. Finally, Diversified Trust Co grew its holdings in Danaher by 75.4% during the second quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock worth $1,090,000 after buying an additional 1,874 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Danaher stock opened at $237.65 on Tuesday. The firm has a market capitalization of $171.65 billion, a P/E ratio of 45.35, a PEG ratio of 4.34 and a beta of 0.85. Danaher Co. has a one year low of $215.68 and a one year high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The business has a fifty day moving average price of $257.38 and a 200-day moving average price of $259.93.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same quarter in the previous year, the firm earned $2.02 EPS. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. As a group, equities research analysts forecast that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of analyst reports. Barclays cut their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 23rd. Robert W. Baird cut their price target on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Monday, November 18th. Stephens restated an “overweight” rating and issued a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Finally, UBS Group decreased their price target on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.